SCHEMBL26436201

SCHEMBL26436201

COC(=O)c1ccc(Nc2ccncc2)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.41
RAD52 P43351 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
NAMPT P43490 1/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
ROCK1 Q13464 1/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39
CHRM2 P08172 1/20 0.39
GRM5 P41594 1/20 0.39
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3634657 0.83 MAPK1 (0.56) MAPK1L3MBTL1KDM4EALDH1A1GAA
SCHEMBL26436231 0.82 P4HTM (0.51) MAPK1L3MBTL1KDM4EALDH1A1RAD52
SCHEMBL23999861 0.78 KMT2A (0.57) MAPK1L3MBTL1KDM4EALDH1A1POLB
SCHEMBL22031779 0.78 MAPK1 (0.62) MAPK1L3MBTL1KDM4EALDH1A1MAPT
Hydrochloric Acid SCHEMBL22031814 0.77 MAPK1 (0.61) MAPK1L3MBTL1KDM4EALDH1A1MAPT
SCHEMBL29260502 0.77 MAPK1 (0.61) MAPK1L3MBTL1KDM4EALDH1A1MAPT
SCHEMBL28594200 0.76 MAPK1 (0.48) MAPK1L3MBTL1KDM4EGLAJAK2
SCHEMBL11390294 0.76 MAPK1 (0.59) MAPK1L3MBTL1KDM4EALDH1A1MAPT
SCHEMBL31598929 0.76 MAPK1 (0.59) MAPK1L3MBTL1KDM4EALDH1A1GAA
SCHEMBL8506592 0.74 MEN1 (0.55) KDM4EALDH1A1POLBMAPTNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127046-A1 G9a INHIBITOR RIKEN (JP) 2023-04-27 US disclosed
US-20230127046-A1 G9a INHIBITOR RIKEN (JP) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127046-A1 G9a INHIBITOR EZH2, BMI1, DOT1L MAPK1 1495/4885L3MBTL1 17/4885KDM4E 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.